Clotrimazole Scaffold as an Innovative Pharmacophore Towards Potent Antimalarial Agents: Design, Synthesis, and Biological and Structure–Activity Relationship Studies

We describe herein the design, synthesis, biological evaluation, and structure–activity relationship (SAR) studies of an innovative class of antimalarial agents based on a polyaromatic pharmacophore structurally related to clotrimazole and easy to synthesize by low-cost synthetic procedures. SAR stu...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 51; no. 5; pp. 1278 - 1294
Main Authors Gemma, Sandra, Campiani, Giuseppe, Butini, Stefania, Kukreja, Gagan, Coccone, Salvatore Sanna, Joshi, Bhupendra P, Persico, Marco, Nacci, Vito, Fiorini, Isabella, Novellino, Ettore, Fattorusso, Ernesto, Taglialatela-Scafati, Orazio, Savini, Luisa, Taramelli, Donatella, Basilico, Nicoletta, Parapini, Silvia, Morace, Giulia, Yardley, Vanessa, Croft, Simon, Coletta, Massimiliano, Marini, Stefano, Fattorusso, Caterina
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 13.03.2008
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We describe herein the design, synthesis, biological evaluation, and structure–activity relationship (SAR) studies of an innovative class of antimalarial agents based on a polyaromatic pharmacophore structurally related to clotrimazole and easy to synthesize by low-cost synthetic procedures. SAR studies delineated a number of structural features able to modulate the in vitro and in vivo antimalarial activity. A selected set of antimalarials was further biologically investigated and displayed low in vitro toxicity on a panel of human and murine cell lines. In vitro, the novel compounds proved to be selective for free heme, as demonstrated in the β-hematin inhibitory activity assay, and did not show inhibitory activity against 14-α-lanosterol demethylase (a fungal P450 cytochrome). Compounds 2, 4e, and 4n exhibited in vivo activity against P. chabaudi after oral administration and thus represent promising antimalarial agents for further preclinical development.
Bibliography:ark:/67375/TPS-3DLT0N32-F
istex:D1865BA272D9361D40A9FB4291D9F07CE34E4BFD
Antifungal activity for compounds 4e,n, 2, and 1 (Table 1), the corresponding experimental details, and elemental analyses for compounds 3a−g and 4a−p (Table 2). This material is available free of charge via the Internet at http://pubs.acs.org.
ISSN:0022-2623
1520-4804
DOI:10.1021/jm701247k